ArticleCureus2025
Quality of Life and the Role of Gender in Patients With Non-Melanoma Skin Cancer in Greece.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Improving quality of life (QoL), is an important factor for patients diagnosed with non-melanoma cell cancer (NMSC). NMSC is the most common and widespread cancer in the European population. Methods To measure QoL, several tools have been created, which try to capture and evaluate it both before and after treatment. The factors that contribute to the evaluation and the degree of impact on the patients' QoL are numerous and sometimes overlap or interact with each other. In the present study, the questionnaire used was the General Health Questionnaire-28 (GHQ-28). Aims and objectives The aim of this study is to map and highlight the population groups whose QoL is affected to a greater extent than others. The final sample of the population consisted of 103 patients (63 men and 40 women) with proven NMSC (via biopsy), who presented to the Dermatology Clinic of the University General Hospital of Patras during the period 2022-2023. Results Of the final study sample, 72 (69.9%) patients had one tumor, 23 (22.3%) patients had two tumors, 6 (5.8%) patients had three tumors, and 2 (1.9%) patients had more than three tumors. In 74.8%, the diameter of the tumor was less than 2 cm, while in 25.2%, it was greater than or equal to 2 cm. Conclusion Our results showed that, in general, the QoL of the female population, in all its aspects (psychology, bodily functions, appearance, etc.), is more affected compared to the corresponding male population, in cases diagnosed with NMSC. The effect may be due to multifaceted factors, such as the outcome of the treatment, the size of the tumor itself, aesthetic interventions, and the change in the patient's daily activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.